Sexually transmitted infections caused by Chlamydia trachomatis may lead to pelvic inflammatory disease, ectopic pregnancy, infertility, and chronic pelvic pain in women. They are associated with increased risk of HIV transmission. Pregnant women may transmit infection to their newborn, causing serious medical complications.
NHANES offers an opportunity to assess the prevalence of chlamydia in the general population and to monitor trends in prevalence as prevention programs are established and expanded.
Examined participants aged 14-39 years were eligible. Public data file includes data for persons aged 18-39 years. See Analytic Notes for information on participants aged 14-17 years.
The BDProbeTec CT Chlamydia trachomatis Amplified DNA Assays are based on the simultaneous amplification and detection of target DNA, using amplification primers and a fluorescent labeled detector probe. The Strand Displacement Amplification (SDA) reagents are dried in two separate disposable microwell strips. The processed sample is added to the Priming Microwell, which contains the amplification primers, fluorescent labeled detector probe, and other reagents necessary for amplification. After incubation, the reaction mixture is transferred to the Amplification Microwell, which contains two enzymes (a DNA polymerase and a restriction endonuclease) necessary for SDA. The Amplification Microwells are sealed to prevent contamination and then incubated in a thermally controlled fluorescent reader which monitors each reaction for the generation of amplified products.
Refer to the Laboratory Method Files section for a detailed description of the laboratory methods used.
There were no changes to the lab methods, lab equipment, or lab site for this component in the NHANES 2013-2014 cycle.
Urinary Chlamydia trachomatis (October 2015)
Urine specimens were processed, stored and shipped to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Laboratory, Centers for Disease Control and Prevention, Atlanta, GA for analysis.
Detailed instructions on specimen collection and processing are discussed in the NHANES Laboratory Procedures Manual (LPM). Vials are stored under appropriate frozen (–30°C) conditions until they are shipped to Division of STD Prevention Laboratory for testing.
The NHANES quality assurance and quality control (QA/QC) protocols meet the 1988 Clinical Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed in the NHANES Laboratory Procedures Manual (LPM).
Mobile Examination Centers (MECs)
Laboratory team
performance is monitored using several techniques. NCHS and contract consultants
use a structured quality assurance evaluation during unscheduled visits to
evaluate both the quality of the laboratory work and the quality-control
procedures. Each laboratory staff person is observed for equipment operation,
specimen collection and preparation; testing procedures and constructive
feedback are given to each staff. Formal retraining sessions are conducted
annually to ensure that required skill levels were maintained.
Analytical Laboratories
NHANES uses several methods
to monitor the quality of the analyses performed by the contract laboratories.
In the MEC, these methods include performing blind split samples collected on
“dry run” sessions. In addition, contract laboratories randomly perform repeat
testing on 2.0% of all specimens.
Progress reports containing any problems encountered during shipping or receipt of specimens, summary statistics for each control pool, QC graphs, instrument calibration, reagents, and any special considerations are submitted to NCHS quarterly. The reports are reviewed for trends or shifts in the data. The laboratories are required to explain any identified areas of concern.
All QC procedures recommended by the manufacturers were followed. Reported results for all assays meet the Division of STD Prevention, Laboratory’s quality control and quality assurance performance criteria for accuracy and precision.
The data were reviewed. Incomplete data or improbable values were sent to the performing laboratory for confirmation.
Refer to the 2013 - 2014 Laboratory Data Overview for general information on NHANES laboratory data.
Demographic and Other Related Variables
The analysis of
NHANES 2013 - 2014 laboratory data must be conducted using the appropriate
survey design and demographic variables. The NHANES
2013-2014 Demographics File contains demographic data, health indicators,
and other related information collected during household interviews as well as
the sample weight variables. The demographics file may be linked to the
laboratory data file using the unique survey participant identifier (i.e.,
SEQN).
Collaborators may obtain NHANES Adolescent STD Special Use Data file through a special agreement. The data set is a SAS file containing 2 variables for examined participants aged 14-17 years. Other interested researchers may use this file in the NCHS Research Data Center (RDC). The variable descriptors and variable names are as follows:
Sequence number-Seqn
Chlamydia result-URXUCL
Detection Limits
Since this data is reported as
qualitative data the use of lower LLODs isn’t applicable.
Exam weights should be used for analyses. Please refer to the NHANES Analytic Guidelines and the on-line NHANES Tutorial for further details on the use of sample weights and other analytic issues.
| Code or Value | Value Description | Count | Cumulative | Skip to Item |
|---|---|---|---|---|
| 1 | Positive | 11 | 11 | |
| 2 | Negative | 665 | 676 | |
| 3 | Indeterminate | 0 | 676 | |
| . | Missing | 32 | 708 |